Skip to content

Mumbai Worksite Tobacco Control Study

Mumbai Worksite Tobacco Control Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01841879
Enrollment
6880
Registered
2013-04-29
Start date
2010-06-30
Completion date
2016-06-30
Last updated
2017-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tobacco Use Cessation

Brief summary

The investigators are designing and testing the effectiveness of an integrated tobacco control and occupational health (OH) intervention aimed at promoting tobacco cessation among workers and supporting the adoption, implementation, and enforcement of tobacco control policies in 20 manufacturing worksites in the greater Mumbai region of India.

Detailed description

Through 6 health education events at the worksites, blue-collar workers (who face dual health risks through their exposures to occupational hazards and their high rates of tobacco use) will gain the knowledge, skills, and social support needed to quit tobacco use. Simultaneously, management will receive OH and tobacco policy consultations to help build a healthy and safe work environment, where workers' hazardous exposures are reduced.

Interventions

Receives an integrated tobacco control and occupational health (OH) intervention (The Healthy, Safe, and Tobacco-Free Worksites program) aimed at promoting tobacco cessation among workers and supporting the adoption, implementation, and enforcement of tobacco control policies. Through six health education events at the worksites, blue-collar workers (who face dual health risks through their exposures to occupational hazards and their high rates of tobacco use) will gain the knowledge, skills, and social support needed to quit tobacco use. Simultaneously, management will receive OH and tobacco policy consultations to help build a healthy and safe work environment, where workers' hazardous exposures are reduced.

Receives abbreviated 2-month delayed intervention designed to provide employees with knowledge and skills to quit tobacco after final data collection time point, as well as one non-tobacco event in between data collection points.

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
Healis-Sekhsaria Institute for Public Health
CollaboratorOTHER
Carelon Research
CollaboratorOTHER
Dana-Farber Cancer Institute
CollaboratorOTHER
Harvard School of Public Health (HSPH)
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Manufacturing worksites located in the Mumbai, Thane, or Raigad districts of India * Employ at least 60% production workers/40% administrative staff OR at employ at least 200 production workers on staff. NOTE: We are defining workers as anyone who is on the company roster, regardless of whether they're permanent or contractual * Companies must be autonomous decision-makers and allow us to function at their worksite * Companies must be willing to provide us with a current employee roster

Exclusion criteria

* Employees do not speak English, Hindi, or Marathi

Design outcomes

Primary

MeasureTime frame
Tobacco use cessation6-month post intervention

Secondary

MeasureTime frame
Changes in company tobacco policy6-month post intervention

Countries

India

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 2, 2026